Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALISKIREN HEMIFUMARATE Cause Motor dysfunction? 173 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 173 reports of Motor dysfunction have been filed in association with ALISKIREN HEMIFUMARATE (Aliskiren). This represents 34.3% of all adverse event reports for ALISKIREN HEMIFUMARATE.

173
Reports of Motor dysfunction with ALISKIREN HEMIFUMARATE
34.3%
of all ALISKIREN HEMIFUMARATE reports
0
Deaths
168
Hospitalizations

How Dangerous Is Motor dysfunction From ALISKIREN HEMIFUMARATE?

Of the 173 reports, 168 (97.1%) required hospitalization, and 166 (96.0%) were considered life-threatening.

Is Motor dysfunction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALISKIREN HEMIFUMARATE. However, 173 reports have been filed with the FAERS database.

What Other Side Effects Does ALISKIREN HEMIFUMARATE Cause?

Nausea (227) Fall (214) Cerebrovascular accident (196) Anxiety (195) Fatigue (186) Confusional state (185) Muscular weakness (184) Hemiparesis (181) Hemiplegia (181) Muscle spasticity (181)

What Other Drugs Cause Motor dysfunction?

DIMETHYL (363) METHOTREXATE (354) NATALIZUMAB (322) INTERFERON BETA-1A (302) ATORVASTATIN (279) AMLODIPINE (278) CARBIDOPA\LEVODOPA (270) METFORMIN (270) IRBESARTAN (240) ESOMEPRAZOLE (233)

Which ALISKIREN HEMIFUMARATE Alternatives Have Lower Motor dysfunction Risk?

ALISKIREN HEMIFUMARATE vs ALISKIREN\HYDROCHLOROTHIAZIDE ALISKIREN HEMIFUMARATE vs ALIZAPRIDE ALISKIREN HEMIFUMARATE vs ALLANTOIN ALISKIREN HEMIFUMARATE vs ALLEGRA ALISKIREN HEMIFUMARATE vs ALLEGRA 24 HOUR

Related Pages

ALISKIREN HEMIFUMARATE Full Profile All Motor dysfunction Reports All Drugs Causing Motor dysfunction ALISKIREN HEMIFUMARATE Demographics